Researchers at Colorado State University have developed a novel method to produce trans-cinnamic acid (tCA) using engineered cyanobacteria. This technology offers a renewable and scalable alternative to fossil fuel-derived or plant-extracted tCA. Utilizing a rhamnose-inducible system, the engineered strain demonstrates up to a four-fold increase in tCA production. It advances sustainable bioproduction, addressing the growing demand for bioactive compounds in pharmaceuticals, cosmetics, and materials science.
Trans-cinnamic acid (tCA) is a valuable precursor in pharmaceuticals, polymers, and cosmetics. Current production relies on fossil fuel-based synthesis or cost-prohibitive plant extraction. Cyanobacteria, capable of converting CO₂ and sunlight into valuable compounds, present a sustainable alternative. By engineering cyanobacteria to produce tCA efficiently, this technology provides a scalable and renewable solution to meet the rising global demand for high-value bioactive compounds.
This innovation leverages a model cyanobacterium to produce tCA using a plant-derived phenylalanine ammonia lyase (PAL) gene regulated by a rhamnose-inducible promoter. The engineered strain achieved up to 500 mg/L of tCA in 14 days under constant light in shake flasks, a four-fold improvement over previous studies. In environmental photobioreactors (ePBRs), the system exhibited 30-50% increased production efficiency under fluctuating light conditions compared to existing methods. This work validates the robustness and scalability of using inducible systems for bioproduction in cyanobacteria, setting the stage for industrial applications. Three constructs have been validated in both E. coli and a model cyanobacteria and are available for research only use from Addgene. Though the use and efficacy of these constructs has yet to be established specifically in additional species, the broad host range plasmid vector they are built on has been known to replicate in other species of Cyanobacteria and Pseudomonas, at a minimum.
• Renewable production: Converts CO₂ and sunlight into tCA, reducing reliance on fossil fuels.
• Improved efficiency: Up to four-fold higher tCA production compared to prior methods.
• Scalability: Demonstrated production in photobioreactors under realistic environmental conditions.
• Non-toxic induction: Utilizes a cost-effective, non-toxic rhamnose-inducible promoter.
• Versatility: Cross-species functionality demonstrated in both cyanobacteria and E. coli.
• Pharmaceutical precursors (e.g., anti-cancer, anti-viral, and anti-bacterial compounds).
• Cosmetic additives (e.g., fragrances, skin care products).
• Biodegradable polymers and plastics.
• Food additives (FDA-approved as Generally Regarded As Safe).
• Sustainable chemical manufacturing.
Material is available through Addgene.
Biological Materials
Christie Peebles
Hayley Ma
Darcy Hunstiger
Jessy McGowan
Jessy.McGowan@colostate.edu
970-491-7100